blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3507302

EP3507302 - CONDITIONALLY ACTIVE POLYPEPTIDES AND METHODS OF GENERATING THEM [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  03.02.2023
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  07.06.2019
FormerThe international publication has been made
Status updated on  10.03.2018
Most recent event   Tooltip28.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
BioAtla, Inc.
11085 Torreyana Road, Suite 100
San Diego, CA 92121 / US
[2021/33]
Former [2019/28]For all designated states
Bioatla, LLC
11085 Torreyana Road, Suite 100
San Diego, CA 92121 / US
Inventor(s)01 / SHORT, Jay, M.
12985 Via Esperia
Del Mar, CA 92014 / US
02 / CHANG, Hwai, Wen
1318 Shadow Hills Drive
San Marcos, CA 92069 / US
03 / FREY, Gerhard
13768 Via Cima Bella
San Diego, CA 92129 / US
 [2019/28]
Representative(s)De Vries & Metman
Overschiestraat 180
1062 XK Amsterdam / NL
[2019/28]
Application number, filing date17847230.422.08.2017
[2019/28]
WO2017US47950
Priority number, dateUS201662382023P31.08.2016         Original published format: US 201662382023 P
[2019/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018044619
Date:08.03.2018
Language:EN
[2018/10]
Type: A1 Application with search report 
No.:EP3507302
Date:10.07.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2018 takes the place of the publication of the European patent application.
[2019/28]
Search report(s)International search report - published on:KR08.03.2018
(Supplementary) European search report - dispatched on:EP06.02.2020
ClassificationIPC:C07K16/18, C07K16/28, G01N33/574, A61K39/00
[2019/28]
CPC:
C07K16/2863 (EP,US); C07K16/46 (KR); A61K47/6803 (EP,US);
A61K47/6809 (EP); A61K47/6849 (EP); A61P35/00 (EP);
C07K14/76 (US); C07K16/005 (US); C07K16/18 (EP);
C07K16/2803 (EP); C12N15/102 (US); C12N5/0638 (KR);
C40B30/04 (US); G01N33/57492 (EP); A61K2039/505 (EP,KR);
C07K2317/14 (EP,US); C07K2317/31 (KR); C07K2317/52 (KR);
C07K2317/565 (KR); C07K2317/622 (US); C07K2317/73 (EP);
C07K2317/92 (EP); C07K2319/00 (KR); G01N2333/47 (KR);
G01N2333/705 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/28]
TitleGerman:BEDINGT AKTIVE POLYPEPTIDE UND VERFAHREN ZUR ERZEUGUNG DAVON[2019/28]
English:CONDITIONALLY ACTIVE POLYPEPTIDES AND METHODS OF GENERATING THEM[2019/28]
French:POLYPEPTIDES CONDITIONNELLEMENT ACTIFS ET LEURS PROCÉDÉS DE GÉNÉRATION[2019/28]
Entry into regional phase28.03.2019National basic fee paid 
28.03.2019Search fee paid 
28.03.2019Designation fee(s) paid 
28.03.2019Examination fee paid 
Examination procedure28.03.2019Examination requested  [2019/28]
04.09.2020Amendment by applicant (claims and/or description)
03.02.2023Despatch of a communication from the examining division (Time limit: M04)
13.06.2023Reply to a communication from the examining division
Fees paidRenewal fee
27.08.2019Renewal fee patent year 03
27.08.2020Renewal fee patent year 04
27.08.2021Renewal fee patent year 05
29.08.2022Renewal fee patent year 06
28.08.2023Renewal fee patent year 07
27.08.2024Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO03105757  (GENENCOR INT [US], et al);
 [X]WO2012033953  (HALOZYME INC [US], et al);
 [XP]WO2016138071  (SHORT JAY M [US], et al);
 [XP]WO2017078839  (BIOATLA LLC [US]);
International search[A]US2009035836  (DATTA DEEPSHIKHA [US], et al);
 [X]US2012258865  (SHORT JAY M [US], et al);
 [X]US2014206596  (SHEN WEI-CHIANG [US], et al);
 [X]WO2016033331  (SHORT JAY M [US], et al);
by applicantUS6329178
 US8709755
 US8921086
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.